Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum.
van der Sluis TC, Beyrend G, van der Gracht ETI, Abdelaal T, Jochems SP, Belderbos RA, Wesselink TH, van Duikeren S, van Haften FJ, Redeker A, Ouboter LF, Beyranvand Nejad E, Camps M, Franken KLMC, Linssen MM, Hohenstein P, de Miranda NFCC, Mei H, Bins AD, Haanen JBAG, Aerts JG, Ossendorp F, Arens R. van der Sluis TC, et al. Among authors: de miranda nfcc. Cell Rep Med. 2023 Mar 21;4(3):100939. doi: 10.1016/j.xcrm.2023.100939. Epub 2023 Feb 15. Cell Rep Med. 2023. PMID: 36796366 Free PMC article.
Cancer-specific T helper shared and neo-epitopes uncovered by expression of the MHC class II master regulator CIITA.
Hos BJ, Tondini E, Camps MGM, Rademaker W, van den Bulk J, Ruano D, Janssen GMC, de Ru AH, van den Elsen PJ, de Miranda NFCC, van Veelen PA, Ossendorp F. Hos BJ, et al. Among authors: de miranda nfcc, de ru ah. Cell Rep. 2022 Nov 22;41(8):111680. doi: 10.1016/j.celrep.2022.111680. Cell Rep. 2022. PMID: 36417866 Free article. No abstract available.
The C-type lectin DCIR contributes to the immune response and pathogenesis of colorectal cancer.
Trimaglio G, Sneperger T, Raymond BBA, Gilles N, Näser E, Locard-Paulet M, Ijsselsteijn ME, Brouwer TP, Ecalard R, Roelands J, Matsumoto N, Colom A, Habch M, de Miranda NFCC, Vergnolle N, Devaud C, Neyrolles O, Rombouts Y. Trimaglio G, et al. Among authors: de miranda nfcc. Sci Rep. 2024 Mar 26;14(1):7199. doi: 10.1038/s41598-024-57941-y. Sci Rep. 2024. PMID: 38532110 Free PMC article.
Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial.
Verschoor YL, van de Haar J, van den Berg JG, van Sandick JW, Kodach LL, van Dieren JM, Balduzzi S, Grootscholten C, IJsselsteijn ME, Veenhof AAFA, Hartemink KJ, Vollebergh MA, Jurdi A, Sharma S, Spickard E, Owers EC, Bartels-Rutten A, den Hartog P, de Miranda NFCC, van Leerdam ME, Haanen JBAG, Schumacher TN, Voest EE, Chalabi M. Verschoor YL, et al. Among authors: de miranda nfcc. Nat Med. 2024 Mar 6. doi: 10.1038/s41591-024-02898-8. Online ahead of print. Nat Med. 2024. PMID: 38448792 No abstract available.
CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors.
Lei X, de Groot DC, Welters MJP, de Wit T, Schrama E, van Eenennaam H, Santegoets SJ, Oosenbrug T, van der Veen A, Vos JL, Zuur CL, de Miranda NFCC, Jacobs H, van der Burg SH, Borst J, Xiao Y. Lei X, et al. Among authors: de miranda nfcc. Cell Mol Immunol. 2024 Apr;21(4):374-392. doi: 10.1038/s41423-024-01133-1. Epub 2024 Feb 21. Cell Mol Immunol. 2024. PMID: 38383773 Free PMC article.
Location matters: spatial dynamics of tumor-infiltrating T cell subsets is prognostic in colon cancer.
Zhu H, Roelands J, Ahmed EI, Stouten I, Hoorntje R, van Vlierberghe RLP, Ijsselsteijn ME, Lei X, de Miranda NFCC, Tollenaar RAEM, Vahrmeijer AL, Bedognetti D, Hendrickx WRL, Kuppen PJK. Zhu H, et al. Among authors: de miranda nfcc. Front Immunol. 2024 Feb 5;15:1293618. doi: 10.3389/fimmu.2024.1293618. eCollection 2024. Front Immunol. 2024. PMID: 38375478 Free PMC article.
Fibroblasts in Orchestrating Colorectal Tumorigenesis and Progression.
Abudukelimu S, de Miranda NFCC, Hawinkels LJAC. Abudukelimu S, et al. Among authors: de miranda nfcc. Cell Mol Gastroenterol Hepatol. 2024;17(5):821-826. doi: 10.1016/j.jcmgh.2024.01.013. Epub 2024 Feb 1. Cell Mol Gastroenterol Hepatol. 2024. PMID: 38307492 Free PMC article. Review.
Multimodal profiling of chordoma immunity reveals distinct immune contextures.
van Oost S, Meijer DM, Ijsselsteijn ME, Roelands JP, van den Akker BEMW, van der Breggen R, Briaire-de Bruijn IH, van der Ploeg M, Wijers-Koster PM, Polak SB, Peul WC, van der Wal RJP, de Miranda NFCC, Bovee JVMG. van Oost S, et al. Among authors: de miranda nfcc. J Immunother Cancer. 2024 Jan 25;12(1):e008138. doi: 10.1136/jitc-2023-008138. J Immunother Cancer. 2024. PMID: 38272563 Free PMC article.
Geriatric predictors of response and adverse events in older patients with cancer treated with immune checkpoint inhibitors: A systematic review.
Özkan A, van den Bos F, Mooijaart SP, Slingerland M, Kapiteijn E, de Miranda NFCC, Portielje JEA, de Glas NA. Özkan A, et al. Among authors: de miranda nfcc. Crit Rev Oncol Hematol. 2024 Feb;194:104259. doi: 10.1016/j.critrevonc.2024.104259. Epub 2024 Jan 9. Crit Rev Oncol Hematol. 2024. PMID: 38199430 Review.
77 results